Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial von Erb‐Zohar, K, Kropeit, D, Scheuenpflug, J, Stobernack, H‐P, Hulskotte, EGJ, Schanke, A, Zimmermann, H, Rübsamen‐Schaeff, H

Volltext

Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials von Breithaupt-Groegler, Kerstin, Coch, Christoph, Coenen, Martin, Donath, Frank, Erb-Zohar, Katharina, Francke, Klaus, Goehler, Karin, Iovino, Mario, Kammerer, Klaus Peter, Mikus, Gerd, Rengelshausen, Jens, Sourgens, Hildegard, Schinzel, Reinhard, Sudhop, Thomas, Wensing, Georg

Volltext